| Hazard Information | Back Directory | [Uses]
Treatment
of cancer. | [in vivo]
Mapatumumab (10 mg/kg; i.p. for three times) controls tumor growth when combined with irradiation[3]. | Animal Model: | Colo205-xenograft–bearing NMRI (nu/nu) nude mice[3] | | Dosage: | 10 mg/kg | | Administration: | Intraperitoneal injection; 10 mg/kg; on days 1, 4, and 8 | | Result: | Showed no significant differences when used alone, but when combined with irradiation (5×3 Gy, d1–5) showed a pronounced tumor regrowth-delay.
|
|
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList15748/0_EN.htm |
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|